Sign Up Today and Learn More About Immunochina Stock
Invest in or calculate the value of your shares in Immunochina or other pre-IPO companies through EquityZen's platform.
Immunochina Stock
Immunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.
About Immunochina Stock
Founded
2015
Industries
Science and Engineering, Health Care, Biotechnology
Immunochina Press Mentions
Stay in the know about the latest news on Immunochina
Stable lentivirus packaging cell line and preparation method therefor
patents • May 04, 2025
Antibody that specifically binds to bcma and application thereof
patents • Apr 02, 2025
Chimeric antigen receptor targeting cd123 and use thereof
patents • Apr 02, 2025
Antibody that specifically binds to bcma and application thereof
patents • Feb 08, 2025
Antibody that specifically binds to bcma and application thereof
patents • Apr 15, 2024
Immunochina Management
Leadership team at Immunochina
CEO
He Ting
Join now and verify your accreditation status to gain access to:
- Immunochina Current Valuation
- Immunochina Stock Price
- Immunochina Management
- Available deals in Immunochina and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Immunochina Cap Table and Funding History by Share Class and Liquidity Preferences
- Immunochina Revenue and Financials
- Immunochina Highlights
- Immunochina Business Model
- Immunochina Risk Factors
- Immunochina Research Report from SACRA Research
Trading Immunochina Stock
How to invest in Immunochina stock?
Accredited investors can buy pre-IPO stock in companies like Immunochina through EquityZen funds. These investments are made available by existing Immunochina shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Immunochina stock?
Shareholders can sell their Immunochina stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
